Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,468.52 50.99 0.35%
TOPIX 1,168.75 2.16 0.19%
HANG SENG 22,760.24 64.23 0.28%

Cambrex To Announce Fourth Quarter 2012 Financial Results On February 6, 2013



Cambrex To Announce Fourth Quarter 2012 Financial Results On February 6, 2013

PR Newswire

EAST RUTHERFORD, N.J., Feb. 1, 2013

EAST RUTHERFORD, N.J., Feb. 1, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE:
CBM) announced that fourth quarter 2012 financial results will be released on
Wednesday, February 6, 2013 after the market closes.

The Company will host a conference call to discuss the financial results.

 

                     Fourth Quarter 2012 Earnings Conference Call
When:                Thursday, February 7, 2013 at 8:30 a.m. Eastern Time
Dial-in:             1-800-723-6604 for U.S.
                     1-785-830-7977 for International
                     Passcode:  6398974
Dial-in Replay:      1-888-203-1112 for U.S.
                     1-719-457-0820 for International
                     Passcode:  6398974
                     Available through Thursday, February 14, 2013
Webcast:             www.cambrex.com

 

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides
products, services and technologies to accelerate the development and
commercialization of small molecule therapeutics.  The Company offers Active
Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug
delivery products for branded and generic pharmaceuticals. Development and
manufacturing capabilities include enzymatic biotransformations, high potency
APIs, high energy chemical synthesis, controlled substances and formulation of
finished dosage form products. For more information, please visit
www.cambrex.com.

SOURCE Cambrex Corporation

Website: http://www.cambrex.com
Contact: Stephanie LaFiura, Investor Relations Associate, +1-201-804-3037,
stephanie.lafiura@cambrex.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement